Literature DB >> 25542733

New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the 'albumin wall'.

A Cuoghi1, M Caiazzo2, E Monari3, E Bellei1, S Bergamini1, L Sereni2, F Aucella4, C Loschiavo5, M Atti2, A Tomasi1.   

Abstract

The uremic syndrome is attributed to the progressive retention of a large number of toxins, which under normal conditions are excreted by the healthy kidneys. Standard dialytic membranes do not purify middle-high molecular weight toxins. Haemodiafiltration with endogenous reinfusion coupled with a highly permeable membrane could break the limit of the 'albumin wall' improving the dialytic depuration without loss of important nutrients. The aim of this study was to evaluate the performance of a new polysulfone membrane, Synclear 0.2, to remove uremic molecules. Surface Enhanced Laser Desorption Ionization-Time of Flight was employed to evaluate the proteomic profile of ultrafiltrate and Electrospray Ionization-Quadruple-ToF coupled with on-chip elution was used for proteins identification. A high and specific permeability for middle-high molecular weight molecules was revealed by mass spectrometry for the investigated membrane. The identified proteins are mostly uremic toxins: their relative abundance, estimated in the ultrafiltrate by exponentially modified protein abundance index, showed a high purification efficiency of the new membrane when compared with conventional ones. In conclusion, Synclear 0.2, used as convective membrane in hemodiafiltration with endogenous reinfusion treatment, permits to break the 'albumin wall', clearing middle-high molecular weight uremic toxins, improving the dialytic treatment purification efficiency.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Proteomics; dialytic membrane; haemodialysis; material characterization; uremic toxins

Mesh:

Substances:

Year:  2014        PMID: 25542733     DOI: 10.1177/0885328214565651

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  6 in total

Review 1.  Proteomic Investigations into Hemodialysis Therapy.

Authors:  Mario Bonomini; Vittorio Sirolli; Luisa Pieroni; Paolo Felaco; Luigi Amoroso; Andrea Urbani
Journal:  Int J Mol Sci       Date:  2015-12-10       Impact factor: 5.923

Review 2.  Examining hemodialyzer membrane performance using proteomic technologies.

Authors:  Mario Bonomini; Luisa Pieroni; Lorenzo Di Liberato; Vittorio Sirolli; Andrea Urbani
Journal:  Ther Clin Risk Manag       Date:  2017-12-18       Impact factor: 2.423

3.  The Extracorporeal Proteome-The Significance of Selective Protein Removal During Dialysis Therapy.

Authors:  Klaus Kratochwill
Journal:  Proteomics Clin Appl       Date:  2018-09-24       Impact factor: 3.494

4.  Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra.

Authors:  Simonetta Palleschi; Paolo M Ghezzi; Giuseppe Palladino; Barbara Rossi; Marino Ganadu; Domenica Casu; Maria Cossu; Giovanni Mattana; Antonio Maria Pinna; Bruno Contu; Tonina Ghisu; Alessandro Monni; Luana Gazzanelli; Maria Cristina Mereu; Franco Logias; Mario Passaghe; Alessandro Amore; Piergiorgio Bolasco
Journal:  BMC Nephrol       Date:  2016-08-26       Impact factor: 2.388

5.  Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients.

Authors:  M Victoria Pendón-Ruiz de Mier; Raquel Ojeda; M Antonia Álvarez-Lara; Ana Navas; Corona Alonso; Javier Caballero-Villarraso; Pedro Aljama; Miguel A Álvarez; Sagrario Soriano; Mariano Rodríguez; Alejandro Martín-Malo
Journal:  BMC Nephrol       Date:  2020-06-15       Impact factor: 2.388

Review 6.  Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives.

Authors:  Stefania Magnani; Mauro Atti
Journal:  Toxins (Basel)       Date:  2021-03-30       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.